Alzheimer's

The drug cuts build up of a key protein

Promising leads
Dr Sorenson said the results of the PBT2 study were one of many encouraging discoveries presented at last week's International Convention for Alzheimer's Disease which showed positive steps were being made towards finding new and better treatments.
Rebecca Wood, chief executive of the Alzheimer's Research Trust, said PBT2 was related to Clioquinol, an ointment used to treat skin infections such as athlete's foot.
She said "Scientists still have a lot of work to do before a drug could be available for patients.
"Much more research is needed even to see whether preventing the amyloid build-up is really a true benefit for patients.
"It would also be necessary to develop a drug that reduced the amyloid without removing it entirely, since a healthy brain still needs amyloid."